tyrosine kinase inhibitor - Globe Thesis

Keyword [tyrosine kinase inhibitor] Result: 161 - 180 \| Page: 9 of 10
161.	Correlation Between PD-L1 Expression And EGFR Mutation In Lung Adenocarcinoma
162.	The Relationship Between Rare EGFR Mutation And Clinicopathological Features Of Non-small Cell Lung Cancer
163.	Modulation Of ALDHA1 Activity Reverses Stem-like Cell-mediated EGFR-TKI Resistance In NSCLC
164.	Clinical Characteristics And Molecular Mechanism Of Transformation From Adenocarcinoma To Small-cell Lung Cancer In EGFR Mutant Patients After EGFR-TKI
165.	Efficacy Of Chemotherapy And Oral Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor In Lung Adenocarcinoma
166.	Study Of An Anti-Tumor Mechanism Of Spleen Tyrosine Kinase Inhibitor Fostamatinib In Melanoma
167.	Analysis Of Clinical Effect And Gene Monitoring Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor In The Treatment Of Advanced Non-small Cell Lung Cancer
168.	Case Report And Literature Review Of Apatinib For Treating Metastatic Colorectal Cancer
169.	Design,Synthesis And Activity Evaluation Of Tyrosine Kinase Inhibitor
170.	The Latest Progress Of Targeted Therapy Non-samll Cell Lung Cancer With Brain Metastases
171.	The Research Of Inhibitory Effect Of EGFR Tyrosine Kinase Inhibitor On Lung Cancer Cells
172.	Sunitinib Inhibits Immune Cytokines
173.	Three New Disease-progression Modes In NSCLC Patients After EGFR-TKIs Treatment By Next-Generation Sequencing Analysis
174.	Docetaxel Plus Platinum Versus Pemetrexed Plus Platinum As Subsequent Treatment Of Advanced Lung Adenocarcinoma With Acquired Resistance To EGFR-TKI,Gefitinib
175.	Clinical Observation Of EGFR-TKIs Combined With WBRT Versus EGFR-TKIs Alone In The Treatment Of Patients With EGFR-sensitive Mutant Lung Adenocarcinoma With Inital Brain Metastases
176.	Clinical Research Of Children With Chronic Myelogenous Leukemia Treated With Targeted Therapy
177.	The Clinical Analysis Of 150 Newly Diagnosed Chronic Myeloid Leukemia
178.	Discontinuation Of Tyrosine Kinase Inhibitors In Patients With Chronic Myeloid Leukemia:a Meta-Analysis
179.	The Analysis Of Treatment Effect By Different Strategies For Advanced Lung Adenocarcinoma Patients With EGFR Sensitive Mutation Positive
180.	Clinical Study Of The Efficacy Of First-generation Tyrosine Kinase Inhibitor Combined With Thalidomide In Patients With Advanced Non-small-cell Lung Cancer With EGFR-sensitive Mutation
<<First <Prev Next> Last>> Jump to